Borrelia burgdorferi infection in a natural population of Peromyscus leucopus mice: A longitudinal study in an area where lyme borreliosis is highly endemic

Journal of Infectious Diseases

Volumn 189, Issue 8, 2004, Pages 1515-1523

  Bunikis, Jonas ^a   Tsao, Jean ^b,c,d   Luke, Catherine J ^a,e   Luna, Maria G ^a,f   Fish, Durland ^c   Barbour, Alan G ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e VICAL INC   (United States)

^f CENTRO DE ESTUDIOS PARASITOLÓGICOS Y DE VECTORES CEPAVE   (Argentina)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; OUTER SURFACE PROTEIN A; OUTER SURFACE PROTEIN C; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE TRANSMISSION; ENDEMIC DISEASE; INCIDENCE; IXODES SCAPULARIS; LARVA; LONGITUDINAL STUDY; LYME DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SPIROCHETE; UNITED STATES;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; BORRELIA BURGDORFERI; CONNECTICUT; DISEASE RESERVOIRS; DNA, BACTERIAL; ENDEMIC DISEASES; FEMALE; IMMUNOENZYME TECHNIQUES; INCIDENCE; IXODES; LONGITUDINAL STUDIES; LYME DISEASE; PEROMYSCUS; POLYMERASE CHAIN REACTION; RODENT DISEASES; SEASONS; SEROEPIDEMIOLOGIC STUDIES;

EID: 2142811000     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/382594     Document Type: Article

References (57)

1. Daniels TJ, Boccia TM, Varde S, et al. Geographic risk for lyme disease and human granulocytic ehrlichiosis in southern New York state. Appl Environ Microbiol 1998; 64:4663-9.
2. Centers for Disease Control and Prevention. Lyme disease - United States, 1996. MMWR Morb Mortal Wkly Rep 1997; 46:531-5.
3. World Health Organization (WHO). Report of WHO workshop on Lyme borreliosis diagnosis and surveillance, Warsaw, Poland [WHO/ CDS/VPH/95]. Geneva: WHO, 1996:141.
4. Levine JF, Wilson ML, Spielman A. Mice as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg 1985; 34:355-60.
5. Spielman A, Wilson ML, Levine JF, Piesman J. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annu Rev Entomol 1985; 30:439-60.
6. Hofmeister EK, Ellis BA, Glass GE, Childs JE. Longitudinal study of infection with Borrelia burgdorferi in a population of Peromyscus leucopus at a Lyme disease-enzootic site in Maryland. Am J Trop Med Hyg 1999; 60:598-609.
7. Donahue JG, Piesman J, Spielman A. Reservoir competence of white-footed mice for Lyme disease spirochetes. Am J Trop Med Hyg 1987; 36:92-6.
8. Mather TN, Wilson ML, Moore SI, Ribeiro JM, Spielman A. Comparing the relative potential of rodents as reservoirs of the Lyme disease spirochete (Borrelia burgdorferi). Am J Epidemiol 1989; 130:143-50.
9. Magnarelli LA, Anderson JF, Hyland KE, Fish D, McAninch JB. Serologic analyses of Peromyscus leucopus, a rodent reservoir for Borrelia burgdorferi, in northeastern United States. J Clin Microbiol 1988; 26:1138-41.
10. Magnarelli LA, Oliver JH Jr, Hutcheson HJ, Boone JL, Anderson JF. Antibodies to Borrelia burgdorferi in rodents in the eastern and southern United States. J Clin Microbiol 1992; 30:1449-52.
11. Stafford KC 3rd, Massung RF, Magnarelli LA, Ijdo JW, Anderson JF. Infection with agents of human granulocytic ehrlichiosis, Lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut. J Clin Microbiol 1999; 37:2887-292.
12. Anderson JF, Johnson RC, Magnarelli LA. Seasonal prevalence of Borrelia burgdorferi in natural populations of white-footed mice, Peromyscus leucopus. J Clin Microbiol 1987; 25:1564-6.
13. Brunet LR, Sellitto C, Spielman A, Telford SR 3rd. Antibody response of the mouse reservoir of Borrelia burgdorferi in nature. Infect Immun 1995; 63:3030-6.
14. Schwan TG, Kime KK, Schrumpf ME, Coe JE, Simpson WJ. Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi). Infect Immun 1989; 57:3445-51.
15. Magnarelli LA, Anderson JF, Flavell RA, Fikrig E. Reactivity of white-footed mouse and raccoon sera to whole cell and recombinant antigens of Borrelia burgdorferi. J Wildl Dis 1995; 31:339-44.
16. de Silva AM, Telford SR 3rd, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 1996; 183:271-5.
17. Kurtenbach K, Dizij A, Voet P, Hauser P, Simon MM. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies. Vaccine 1997; 15:1670-4.
18. Schug MD, Vessey SH, Korytko AI. Longevity and survival in a population of white-footed mice (Peromyscus leucopus). J Mammal 1991; 72:360-6.
19. Tsao J, Barbour AG, Luke CJ, Fikrig E, Fish D. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks. Vector Borne Zoonotic Dis 2001; 1:65-74.
20. Levin M, Papero M, Fish D. Feeding density influences acquisition of Borrelia burgdorferi in larval Ixodes scapularis (Acari: Ixodidae). J Med Entomol 1997; 34:569-72.
21. Schwan TG, Burgdorfer W, Garon CF. Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect Immun 1988; 56:1831-6.
22. Erdile LF, Brandt MA, Warakomski DJ, et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun 1993; 61:81-90.
23. Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 1990; 250:553-6.
24. Sadziene A, Wilske B, Ferdows MS, Barbour AG. The cryptic OspC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect Immun 1993; 61:2192-5.
25. Luke CJ, Huebner RC, Kasmiersky V, Barbour AG. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi. Vaccine 1997; 15:739-46.
26. Barbour AG, Tessier SL, Todd WJ. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun 1983; 41:795-804.
27. Barbour AG, Hayes SF, Heiland RA, Schrumpf ME, Tessier SL. A Borrelia-specific monoclonal antibody binds to a flagellar epitope. Infect Immun 1986; 52:549-54.
28. Bunikis J, Luke CJ, Bunikiene E, Bergstrom S, Barbour AG. A surface-exposed region of a novel outer membrane protein (P66) of Borrelia spp. is variable in size and sequence. J Bacteriol 1998; 180:1618-23.
29. Simpson WJ, Cieplak W, Schrumpf ME, Barbour AG, Schwan TG. Nucleotide sequence and analysis of the gene in Borrelia burgdorferi encoding the immunogenic P39 antigen. FEMS Microbiol Lett 1994; 119:381-7.
30. Volkman DJ, Luft BJ, Gorevic PD, Schultz J, Padovano L. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody. J Immunol 1991; 146:3177-82.
31. Bunikis J, Barbour AG. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Infect Immun 1999; 67:2874-83.
32. Otis DL, Burnham KP, White GC, Anderson DR. Statistical inference from capture data on closed animal populations. Wildlife Monogr 1978: 1-135.
33. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392-400.
34. Fish D. Environmental risk and prevention of Lyme disease. Am J Med 1995; 98:2S-8S.
35. Elkinton JS, Healy WM, Buonaccorsi JP, et al. Interactions among gypsy moths, white-footed mice, and acorns. Ecology 1996; 77:2332-42.
36. Brooks RT, Smith HR, Healy WM. Small-mammal abundance at three elevations on a mountain in central Vermont, USA: a sixteen-year record. For Ecol Manage 1998; 110:181-93.
37. LoGiudice K, Ostfeld RS, Schmidt KA, Keesing F. The ecology of infectious disease: effects of host diversity and community composition on Lyme disease risk. Proc Natl Acad Sci USA 2003; 100:567-71.
38. Hansen L, Batzli GO. Influence of supplemental food on local populations of Peromyscus leucopus. J Mammal 1979; 60:335-42.
39. Sadziene A, Rosa PA, Thompson PA, Hogan DM, Barbour AG. Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med 1992; 176:799-809.
40. Piesman J, Mather TN, Dammin GJ, Telford SR 3rd, Lastavica CC, Spielman A. Seasonal variation of transmission risk of Lyme disease and human babesiosis. Am J Epidemiol 1987; 126:1187-9.
41. Mather TN, Telford SR 3rd, Adler GH. Absence of transplacental transmission of Lyme disease spirochetes from reservoir mice (Peromyscus leucopus) to their offspring. J Infect Dis 1991; 164:564-7.
42. Schwartz I, Bittker S, Bowen SL, Cooper D, Pavia C, Wormser GP. Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis 1993; 12:879-82.
43. Bunikis J, Barbour AG. Laboratory testing for suspected Lyme disease. Med Clin North Am 2002; 86:311-40.
44. McLean R, Ubico S, Cooksey L. Experimental infection of the eastern chipmunk (Tamias striatus) with the Lyme disease spirochete (Borrelia burgdorferi). J Wildl Dis 1993; 29:527-32.
45. Wang G, Ojaimi C, Iyer R, et al. Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun 2001; 69:4303-12.
46. Piesman J, Dolan MC, Happ CM, et al. Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice. Infect Immun 1997; 65:4043-7.
47. Probert WS, Crawford M, Cadiz RB, LeFebvre RB. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J Infect Dis 1997; 175:400-5.
48. Qiu WG, Bosler EM, Campbell JR, et al. A population genetic study of Borrelia burgdorferi sensu stricto from eastern Long Island, New York, suggested frequency-dependent selection, gene flow and host adaptation. Hereditas 1997; 127:203-16.
49. Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 1999; 151:15-30.
50. Poland J, Barnes A. Plague. In: Steele J, ed. CRC handbook series in zoonoses. Section A: Bacterial, rickettsial, and mycotic diseases. Vol. 1. Boca Raton: CRC Press, 1979:515-97.
51. Calisher CH, Sweeney W, Mills JN, Beaty BJ. Natural history of Sin Nombre virus in western Colorado. Emerg Infect Dis 1999; 5:126-34.
52. Gruwell JA, Fogarty CL, Bennett SG, et al. Role of peridomestic birds in the transmission of St. Louis encephalitis virus in southern California. J Wildl Dis 2000; 36:13-34.
53. Kartman L, Hudson BW. The effect of flea control on Yersinia (Pasteurella) pestis antibody rates in the California vole, Microtus californicus, and its epizootiological implications. Bull World Health Organ 1971; 45:295-301.
54. Hudson BW, Goldenberg MI, Quan TJ. Serologic and bacteriologic studies on the distribution of plague infection in a wild rodent plague pocket in the San Francisco Bay area of California. J Wildl Dis 1972; 8:278-86.
55. Childs JE, Ksiazek TG, Rollin PE, et al. Hantaviruses and their rodent reservoirs in the United States. In: Halverson WS, Crabb AC, eds. Proceedings of the 16th Vertebrate Pest Conference. Davis, CA: University of California Press, 1994:188-91.
56. Levin ML, Fish D. Immunity reduces reservoir host competence of Peromyscus leucopus for Ehrlichia phagocytophila. Infect Immun 2000; 68:1514-8.
57. Calisher CH, Mills JN, Sweeney WP, et al. Do unusual site-specific population dynamics of rodent reservoirs provide clues to the natural history of hantaviruses? J Wildl Dis 2001; 37:280-8.